Silence Therapeutics Statistics
Total Valuation
SLNCF has a market cap or net worth of 280.55 million. The enterprise value is 144.07 million.
| Market Cap | 280.55M |
| Enterprise Value | 144.07M |
Important Dates
The last earnings date was Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 141.69M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +20.42% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 25.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.13 |
| PB Ratio | 2.49 |
| P/TBV Ratio | 2.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.01 |
| EV / Sales | 5.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.03 |
Financial Position
The company has a current ratio of 8.81, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.81 |
| Quick Ratio | 7.96 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.13% and return on invested capital (ROIC) is -33.48%.
| Return on Equity (ROE) | -53.13% |
| Return on Assets (ROA) | -20.96% |
| Return on Invested Capital (ROIC) | -33.48% |
| Return on Capital Employed (ROCE) | -43.50% |
| Revenue Per Employee | 238,802 |
| Profits Per Employee | -616,612 |
| Employee Count | 116 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.80% in the last 52 weeks. The beta is 1.19, so SLNCF's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -78.80% |
| 50-Day Moving Average | 1.01 |
| 200-Day Moving Average | 3.16 |
| Relative Strength Index (RSI) | 90.93 |
| Average Volume (20 Days) | 5 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.48 |
Income Statement
In the last 12 months, SLNCF had revenue of 27.70 million and -71.53 million in losses. Loss per share was -1.52.
| Revenue | 27.70M |
| Gross Profit | 18.64M |
| Operating Income | -72.23M |
| Pretax Income | -70.93M |
| Net Income | -71.53M |
| EBITDA | -71.65M |
| EBIT | -72.23M |
| Loss Per Share | -1.52 |
Balance Sheet
The company has 136.53 million in cash and 60,000 in debt, giving a net cash position of 136.47 million.
| Cash & Cash Equivalents | 136.53M |
| Total Debt | 60,000 |
| Net Cash | 136.47M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 112.74M |
| Book Value Per Share | 2.39 |
| Working Capital | 150.53M |
Cash Flow
In the last 12 months, operating cash flow was -70.81 million and capital expenditures -215,000, giving a free cash flow of -71.02 million.
| Operating Cash Flow | -70.81M |
| Capital Expenditures | -215,000 |
| Free Cash Flow | -71.02M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.28%, with operating and profit margins of -260.73% and -258.21%.
| Gross Margin | 67.28% |
| Operating Margin | -260.73% |
| Pretax Margin | -256.04% |
| Profit Margin | -258.21% |
| EBITDA Margin | -258.64% |
| EBIT Margin | -260.73% |
| FCF Margin | n/a |
Dividends & Yields
SLNCF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.42% |
| Shareholder Yield | n/a |
| Earnings Yield | -25.50% |
| FCF Yield | -25.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SLNCF has an Altman Z-Score of 1.6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.6 |
| Piotroski F-Score | n/a |